{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:36:58Z","timestamp":1774571818498,"version":"3.50.1"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,12,15]]},"DOI":"10.2169\/internalmedicine.7357-21","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T22:08:56Z","timestamp":1623449336000},"page":"3957-3962","source":"Crossref","is-referenced-by-count":2,"title":["Myelin Oligodendrocyte Glycoprotein-antibody-associated Disorder Presenting with Corticomeningeal Encephalitis Prior to the Onset of Optic Neuritis"],"prefix":"10.2169","volume":"60","author":[{"given":"Takuya","family":"Ataka","sequence":"first","affiliation":[{"name":"Department of Neurology, Oita University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oita University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuro","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oita University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. L\u00f3pez-Chiriboga AS, Majed M, Fryer J, et al. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol 75: 1355-1363, 2018.","DOI":"10.1001\/jamaneurol.2018.1814"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Akaishi T, Sato DK, Takahashi T, Nakashima I. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein. Neurochem Int 130: 104319, 2019.","DOI":"10.1016\/j.neuint.2018.10.016"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ogawa R, Nakashima I, Takahashi T, et al. MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 4: e322, 2017.","DOI":"10.1212\/NXI.0000000000000322"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Al-Araji A, Kidd DP. Neuro-Beh\u00e7et's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8: 192-204, 2009.","DOI":"10.1016\/S1474-4422(09)70015-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Borhani-Haghighi A, Kardeh B, Banerjee S, et al. Neuro-Behcet's disease: an update on diagnosis, differential diagnoses, and treatment. Mult Scler Relat Disord 39: 101906, 2019.","DOI":"10.1016\/j.msard.2019.101906"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. International Team for the Revision of the International Criteria for Beh\u00e7et's Disease (ITR-ICBD). The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28: 338-347, 2014.","DOI":"10.1111\/jdv.12107"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kalra S, Silman A, Akman-Demir G, et al. Diagnosis and management of Neuro-Beh\u00e7et's disease: international consensus recommendations. J Neurol 261: 1662-1676, 2014.","DOI":"10.1007\/s00415-013-7209-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fujimori J, Takahashi T, Matsumoto Y, et al. Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Beh\u00e7et's disease. J Neuroimmunol 334: 577002, 2019.","DOI":"10.1016\/j.jneuroim.2019.577002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fujimori J, Takai Y, Nakashima I, et al. Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry 88: 534-536, 2017.","DOI":"10.1136\/jnnp-2016-315094"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nagabushana D, Shah R, Pendharkar H, et al. MOG antibody seropositive aseptic meningitis: a new clinical phenotype. J Neuroimmunol 333: 476960, 2019.","DOI":"10.1016\/j.jneuroim.2019.05.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Narayan RN, Wang C, Sguigna P, Husari K, Greenberg B. Atypical anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations. Mult Scler Relat Disord 27: 30-33, 2019.","DOI":"10.1016\/j.msard.2018.10.003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Suzuki T, Maekawa K, Matsuo K, et al. Aseptic meningitis as an initial manifestation of anti-myelin oligodendrocyte glycoprotein antibody-associated disease. Intern Med 58: 3319-3321, 2019.","DOI":"10.2169\/internalmedicine.2845-19"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zhong X, Chang Y, Tan S, et al. Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome. BMC Neurol 19: 94, 2019.","DOI":"10.1186\/s12883-019-1324-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Leinert J, Neumaier-Probst E, Kutschke G, Tenenbaum T. MOG antibody associated demyelinating syndrome presenting as aseptic meningitis in a 6-year-old boy. Mult Scler Relat Disord 41: 102050, 2020.","DOI":"10.1016\/j.msard.2020.102050"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vibha D, Singh RK, Salunkhe M, Dash D, Tripathi M. MOG antibody syndrome presenting as aseptic meningitis: an evolving spectrum. Neurol Sci 42: 321-323, 2021.","DOI":"10.1007\/s10072-020-04558-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shen W, Zhang Y, Zhou C, Shen Y. Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis. BMC Neurol 21: 10, 2021.","DOI":"10.1186\/s12883-020-02041-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Jarius S, Pellkofer H, Siebert N, et al. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: results from 163 lumbar punctures in 100 adult patients. J Neuroinflammation 17: 261, 2020.","DOI":"10.1186\/s12974-020-01824-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fujimori J, Ogawa R, Murata T, Jin K, Yazawa Y, Nakashima I. Unilateral chronic pulsatile headache as the single manifestation of anti-MOG antibody-associated unilateral cerebral cortical encephalitis. J Neuroimmunol 346: 577322, 2020.","DOI":"10.1016\/j.jneuroim.2020.577322"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jarius S, Ruprecht K, Kleiter I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13: 280, 2016.","DOI":"10.1186\/s12974-016-0718-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chen KA, Brilot F, Dale RC, Lafferty AR, Andrews PI. Hashimoto's encephalopathy and anti-MOG antibody encephalitis: 50 years after Lord Brain's description. Eur J Paediatr Neurol 21: 898-901, 2017.","DOI":"10.1016\/j.ejpn.2017.06.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nan D, Zhang Y, Han J, Jin T. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature. Neurol Sci 42: 847-855, 2021.","DOI":"10.1007\/s10072-020-04942-0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/24\/60_7357-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T03:18:59Z","timestamp":1639797539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/24\/60_7357-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":21,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7357-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,15]]},"article-number":"7357-21"}}